Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Molecular Devices to Attend Fourth Annual European Lab Automation (ELA) 2014
Wednesday, April 16, 2014
Molecular Devices® will be showcasing the next generation SpectraMax® MiniMax™ 300 imaging cytometer.

Life Technologies Releases New Research Tool
Tuesday, April 08, 2014
Oncomine NGS RNA-Seq Gene Expression Browser extends the Oncomine NGS Power Tools product offering.

Eppendorf Launches its New Spring 2014 Advantage Offer
Saturday, April 05, 2014
New offer enables customers to purchase products at favourable prices.

Metabolon Launches Fourth Generation DiscoveryHD4™ Metabolomics Platform
Saturday, April 05, 2014
New technology advancements have potential to lead the way to new scientific breakthroughs, novel biomarkers and discoveries, and support diagnostic product pipeline.

Bio-Rad Launches Precision Blue™ Real-Time PCR Dye
Friday, April 04, 2014
Bio-Rad Laboratories, Inc. today announced the launch of its Precision Blue real-time PCR dye, making it easier for researchers to set up real-time PCR (qPCR) experiments.

Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform
Thursday, April 03, 2014
Expansion to identify novel biomarkers predictive of cancer outcomes.

Identifying Epigenetic Biomarkers for Prostate Cancer
Tuesday, April 01, 2014
IDT qPCR assays and probes facilitate the development of predictive epigenetic biomarkers.

Techne’s New In Situ Hybridization Adapter
Friday, March 28, 2014
Delivers a quick, economical solution for 96-well thermal cycler owners.

GenTegra LLC Launches New RNA Ambient Stabilization Product
Friday, March 28, 2014
Protect RNA samples immediately, and for all its tomorrows.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 717
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv